Search | Clinical Trials Finder

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–14 of 14 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Condition: Chronic Prostatitis With Chronic Pelvic Pain Syndrome Clear all

Conditions: Interstitial Cystitis, Chronic Prostatitis
Interventions: Not listed
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 424 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2014
U.S. locations: 8
States / cities: Birmingham, Alabama • Los Angeles, California • Stanford, California + 5 more

Conditions: Chronic Interstitial Cystitis, Bladder Pain Syndrome, Cystitis, Interstitial, Painful Bladder Syndrome, Cystitis, Chronic Interstitial, Interstitial Cystitis, Interstitial Cystitis, Chronic, Interstitial Cystitis (Chronic) With Hematuria, Interstitial Cystitis (Chronic) Without Hematuria, Chronic Prostatitis, Chronic Prostatitis With Chronic Pelvic Pain Syndrome
Interventions: Psychosocial Treatment, Attention Control; Behavioral
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Prostatitis
Interventions: Viagra (sildenafil citrate); Drug
Lead sponsor: University of Washington; Other
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Chronic Interstitial Cystitis, Bladder Pain Syndrome, Painful Bladder Syndrome, Cystitis, Interstitial, Cystitis, Chronic Interstitial, Interstitial Cystitis, Interstitial Cystitis, Chronic, Interstitial Cystitis (Chronic) With Hematuria, Interstitial Cystitis (Chronic) Without Hematuria, Chronic Prostatitis, Chronic Prostatitis With Chronic Pelvic Pain Syndrome
Interventions: Psychosocial Treatment, Pelvic Floor Physical Therapy; Behavioral · Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Franklin, Tennessee

Conditions: Erectile Dysfunction Due to Arterial Insufficiency, Erectile Dysfunction, Erectile Dysfunction Due to Arterial Disease, Chronic Pelvic Pain Syndrome, Chronic Prostatitis, Erectile Dysfunction Following Radical Prostatectomy, Erectile Dysfunction Following Radiation Therapy
Interventions: Focused shockwave, Radial wave, Sham treatment; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 40 Years and older · Male only
Enrollment: 186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Chronic Prostatitis With Chronic Pelvic Pain Syndrome, Prostatitis
Interventions: Not listed
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 147 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Chronic Prostatitis With Chronic Pelvic Pain Syndrome
Interventions: Tanezumab, Placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 23
States / cities: Birmingham, Alabama • Goodyear, Arizona • Litchfield Park, Arizona + 17 more

Conditions: Prostatitis, Chronic Prostatitis With Chronic Pelvic Pain Syndrome
Interventions: laparoscopic prostatectomy; Procedure
Lead sponsor: The Krongrad Institute; Other
Eligibility: 30 Years and older · Male only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2015
U.S. locations: 1
States / cities: Aventura, Florida

Conditions: Chronic Prostatitis With Chronic Pelvic Pain Syndrome, Chronic Bacterial Prostatitis, Asymptomatic Inflammatory Prostatitis, Painful Bladder Syndrome, Cystitis, Interstitial
Interventions: Genomic and proteomic biomarker discovery; Genetic
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2011
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Prostatitis, Chronic Prostatitis With Chronic Pelvic Pain Syndrome
Interventions: CC-10004; Drug
Lead sponsor: Kenneth Peters, MD; Other
Eligibility: 18 Years and older · Male only
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Royal Oak, Michigan

Conditions: Chronic Prostatitis With Chronic Pelvic Pain Syndrome
Interventions: Cromolyn Sodium, Cetirizine Hydrochloride; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 21 Years to 80 Years · Male only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Chronic Prostatitis With Chronic Pelvic Pain Syndrome
Interventions: D-Cycloserine, Placebo (for D-cycloserine); Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Chronic Prostatitis, Chronic Pelvic Pain Syndrome
Interventions: AQX-1125 200 mg, Placebo; Drug
Lead sponsor: Aquinox Pharmaceuticals (Canada) Inc.; Industry
Eligibility: 18 Years to 80 Years · Male only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 23
States / cities: Homewood, Alabama • Mobile, Alabama • Tucson, Arizona + 19 more

Conditions: Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Interventions: Silodosin 8 mg, Placebo, Silodosin 4 mg; Drug
Lead sponsor: Watson Pharmaceuticals; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 153 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 22
States / cities: San Diego, California • Denver, Colorado • Columbus, Georgia + 19 more

Search by objective public record fields.

Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis

Optimizing Psychosocial Treatment of Interstitial Cystitis/Bladder Pain Syndrome

Trial of Viagra' in Men With Chronic Pelvic Pain Syndrome Type III

Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment

Efficacy of Low-intensity Shockwave vs Radial Wave for Treatment of Erectile Dysfunction and Pelvic Pain

Chemokine Mechanisms in Chronic Pelvic Pain

An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis

Laparoscopic Prostatectomy for Chronic Prostatitis

Diagnostic Challenges in IC (and Male CPPS)

An Open-Label Study of CC-10004 for Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Mast Cells in Male Pelvic Pain and and Lower Urinary Tract Dysfunction

Treating Urological Chronic Pelvic Pain Syndrome (UCPPS) Pain

Efficacy and Safety of AQX-1125 in Subjects With Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Use of Silodosin to Treat Moderate to Severe Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome.